Lotus Eye Hospital & Institute Ltd
NSE: LOTUSEYE BSE: 532998
₹98.22
(-4.38%)
Wed, 01 Apr 2026, 09:46 pm
Market Cap2.11B
PE Ratio313.20
Dividend0
Health Services
Medical/Nursing Services
24.5KLotus Eye Hospital & Institute Analysis
dividend
- Unable to calculate sustainability of dividends as Lotus Eye Hospital and Institute has not reported any payouts.
- Unable to evaluate Lotus Eye Hospital and Institute's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Lotus Eye Hospital and Institute's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Lotus Eye Hospital and Institute is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Lotus Eye Hospital and Institute is profitable, therefore cash runway is not a concern.
- Lotus Eye Hospital and Institute is profitable, therefore cash runway is not a concern.
- Lotus Eye Hospital and Institute has no debt, it does not need to be covered by operating cash flow.
- Lotus Eye Hospital and Institute has no debt, it does not need to be covered by short term assets.
- Lotus Eye Hospital and Institute's cash and other short term assets cover its long term commitments.
- Lotus Eye Hospital and Institute has no debt compared to 5 years ago when it was 1.7%.
- Lotus Eye Hospital and Institute has no debt, therefore coverage of interest payments is not a concern.
- Lotus Eye Hospital and Institute has no debt.
- High level of physical assets or inventory.
management
- The tenure for the Lotus Eye Hospital and Institute board of directors is about average.
- The average tenure for the Lotus Eye Hospital and Institute management team is over 5 years, this suggests they are a seasoned and experienced team.
misc
- Lotus Eye Hospital and Institute is not covered by any analysts.
- Lotus Eye Hospital and Institute has significant price volatility in the past 3 months.
past
- Lotus Eye Hospital and Institute's 1-year earnings growth exceeds its 5-year average (221.8% vs 64.2%)
- Lotus Eye Hospital and Institute has delivered over 20% year on year earnings growth in the past 5 years.
- Lotus Eye Hospital and Institute has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Lotus Eye Hospital and Institute's earnings growth has exceeded the IN Healthcare industry average in the past year (221.8% vs 14.4%).
- Lotus Eye Hospital and Institute used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
- Lotus Eye Hospital and Institute has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- Lotus Eye Hospital and Institute is good value based on assets compared to the IN Healthcare industry average.
- 532998 outperformed the Healthcare industry which returned 9.1% over the past year.
- 532998 outperformed the Market in India which returned -14.5% over the past year.
- BSE:532998 is up 18.2% outperforming the Healthcare industry which returned 5.4% over the past month.
- BSE:532998 is up 18.2% outperforming the market in India which returned 8% over the past month.
- Lotus Eye Hospital and Institute's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Lotus Eye Hospital and Institute's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Lotus Eye Hospital and Institute is overvalued based on earnings compared to the IN Healthcare industry average.
- Lotus Eye Hospital and Institute is overvalued based on earnings compared to the India market.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800